ANXA5 and fibrosis: Platelet phenotype was assessed via microfluidic assays and flow cytometry, evaluating adhesion and fibrinogen receptor activation and Annexin V. Patients were stratified according to liver stiffness measurement (LSM) into low fibrosis MASLD (≤ F2) and advanced fibrosis/cirrhosis (F3–F4).